chr5-40955428-G-C
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The ENST00000313164.10(C7):c.1135G>C(p.Gly379Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,612,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G379A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000313164.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C7 | NM_000587.4 | c.1135G>C | p.Gly379Arg | missense_variant | 10/18 | ENST00000313164.10 | NP_000578.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C7 | ENST00000313164.10 | c.1135G>C | p.Gly379Arg | missense_variant | 10/18 | 1 | NM_000587.4 | ENSP00000322061 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000133 AC: 33AN: 247290Hom.: 0 AF XY: 0.000164 AC XY: 22AN XY: 134218
GnomAD4 exome AF: 0.000149 AC: 218AN: 1459842Hom.: 0 Cov.: 30 AF XY: 0.000145 AC XY: 105AN XY: 726218
GnomAD4 genome AF: 0.000177 AC: 27AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74472
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | May 27, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2022 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 11252001, 8871666, 12116267, 15554930, 12869030, 17407100, 28368462, 31203817, 9218625, 31589614, 34426522) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 379 of the C7 protein (p.Gly379Arg). This variant is present in population databases (rs121964921, gnomAD 0.02%). This missense change has been observed in individual(s) with C7 deficiency (PMID: 9218625, 12869030, 15554930). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as G357R. ClinVar contains an entry for this variant (Variation ID: 12108). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt C7 protein function. For these reasons, this variant has been classified as Pathogenic. - |
Complement component 7 deficiency Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 29, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2004 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 07, 2022 | - - |
C7-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 22, 2024 | The C7 c.1135G>C variant is predicted to result in the amino acid substitution p.Gly379Arg. This variant is also described using legacy nomenclature as p.Gly357Arg, has been reported in the homozygous or heterozygous states in multiple individuals/families with C7 deficiency (Fernie et al. 1997. PubMed ID: 9218625; Vázquez-Bermúdez et al. 2003. PubMed ID: 12869030; Barroso et al. 2004. PubMed ID: 15554930). This variant is reported in 0.020% of alleles in individuals of Latino descent in gnomAD. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at